Co-Authored By:
Besides, what is the difference between CLL and CML?
The difference between them is the type of white blood cell that has become cancerous. In CLL, the abnormal cells develop from early blood cells called the lymphoid blood stem cells. In CML, the abnormal leukaemia cells develop from early blood cells called the myeloid blood stem cells. They become myelocytes.
In this regard, which leukemia is most dangerous?
In highly lethal type of leukemia, cancer gene predicts treatment response. Summary: Patients with the most lethal form of acute myeloid leukemia (AML) – based on genetic profiles of their cancers – typically survive for only four to six months after diagnosis, even with aggressive chemotherapy.
Chronic myeloid leukemia (CML) affects approximately one in 100,000 individuals per year and accounts for 15 percent of all new cases of leukemia in the Western Hemisphere. Before the development of targeted therapy with tyrosine kinase inhibitors (TKIs), the median survival was five to seven years.